ARGENX SE's ticker is ARGX and the CUSIP is 04016X101. A total of 290 filers reported holding ARGENX SE in Q2 2023. The put-call ratio across all filers is 1.54 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $743,219,245 | +66.8% | 1,511,745 | +32.2% | 0.63% | +72.9% |
| Q2 2023 | $445,608,690 | +5.1% | 1,143,378 | +0.5% | 0.36% | -6.2% |
| Q1 2023 | $423,983,371 | -24.5% | 1,137,966 | -23.3% | 0.39% | -31.6% |
| Q4 2022 | $561,763,978 | +2.7% | 1,482,892 | -4.3% | 0.57% | +4.6% |
| Q3 2022 | $546,897,000 | -6.6% | 1,549,065 | +0.2% | 0.54% | -6.8% |
| Q2 2022 | $585,456,000 | +82.5% | 1,545,227 | +51.9% | 0.58% | +147.5% |
| Q1 2022 | $320,801,000 | +11.1% | 1,017,415 | +23.4% | 0.24% | +29.0% |
| Q4 2021 | $288,757,000 | +14.9% | 824,571 | -0.9% | 0.18% | +13.0% |
| Q3 2021 | $251,308,000 | +11.1% | 832,145 | +10.8% | 0.16% | +8.0% |
| Q2 2021 | $226,210,000 | +14.1% | 751,355 | +4.4% | 0.15% | +3.4% |
| Q1 2021 | $198,230,000 | +61.4% | 719,815 | +72.4% | 0.14% | +64.8% |
| Q4 2020 | $122,820,000 | +9.5% | 417,627 | -2.3% | 0.09% | -2.2% |
| Q3 2020 | $112,192,000 | +9.9% | 427,365 | -5.8% | 0.09% | -2.2% |
| Q2 2020 | $102,131,000 | +90.6% | 453,450 | +11.5% | 0.09% | +41.5% |
| Q1 2020 | $53,577,000 | +21.4% | 406,718 | +47.9% | 0.06% | +44.4% |
| Q4 2019 | $44,140,000 | +77.3% | 274,981 | +25.9% | 0.04% | +73.1% |
| Q3 2019 | $24,893,000 | -53.4% | 218,434 | -42.1% | 0.03% | -50.9% |
| Q2 2019 | $53,391,000 | -16.1% | 377,108 | -26.0% | 0.05% | -15.9% |
| Q1 2019 | $63,652,000 | +30.7% | 509,868 | +0.6% | 0.06% | +16.7% |
| Q4 2018 | $48,705,000 | +25.6% | 506,971 | -0.8% | 0.05% | +50.0% |
| Q3 2018 | $38,771,000 | +40.9% | 511,221 | +54.0% | 0.04% | +33.3% |
| Q2 2018 | $27,511,000 | +4.7% | 332,013 | +1.6% | 0.03% | +3.8% |
| Q1 2018 | $26,283,000 | +45.1% | 326,737 | +13.9% | 0.03% | +44.4% |
| Q4 2017 | $18,109,000 | +545.8% | 286,812 | +129.5% | 0.02% | +500.0% |
| Q3 2017 | $2,804,000 | +5.5% | 124,966 | -0.3% | 0.00% | 0.0% |
| Q2 2017 | $2,657,000 | – | 125,285 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SAL Trading, LLC | 36,100 | $17,747,843 | 24.88% |
| Artia Global Partners LP | 49,238 | $24,206,878 | 10.06% |
| Paradigm Biocapital Advisors LP | 261,443 | $128,533,222 | 8.72% |
| Darwin Global Management, Ltd. | 45,615 | $22,425,702 | 7.89% |
| Avoro Capital Advisors LLC | 1,000,000 | $491,630,000 | 7.67% |
| Bellevue Group AG | 911,530 | $448,135,494 | 7.22% |
| Eagle Health Investments LP | 64,400 | $31,660,972 | 6.98% |
| DCF Advisers, LLC | 22,000 | $10,815,860 | 5.89% |
| SAL Trading, LLC | 8,149 | $4,006,293 | 5.62% |
| RTW INVESTMENTS, LP | 507,195 | $249,352,278 | 5.26% |